Kexin Liu received his B.S. degree in Clinical Medicine and M.S. degree in Pharmacology from Dalian medical University in China and Ph. D. degree in Pharmacy in The University of Tokyo (Laboratory of Yuichi Sugiyama, Department of Pharmaceutics, Faculty of Pharmaceutical Sciences) in Japan. The focus of his research is on the molecular pharmacokinetics of transport in liver, intestine, kidney as well as transporter-mediated DDI and MDR. Prof. Kexin Liu is a co-author of more than 250 publications in international journals and a first or corresponding author in the famous journals such as Hepatology?Biochem Pharmacol, Drug Metab Dispos, J Pharmacol Exp Ther? Am J Physiol? Pharm Res? Toxical Appl Pharm?Eur J Pharm Sci and 50 book chapters as well as 30 review articles. He serves as a vice president of CSSX from 2005 and a dean in College of Pharmacy in Dalian Medical University from 2004.2-2015.1.

Igor Grachev, M.D., Ph.D. is a Neurologist, Psychiatrist, Neuroscientist, Drug Developer, Translational Medicine/POC, Clinical Development, Medical Affairs and Imaging expert with over 20 years of extensive Pharma industry, academic and CRO biomedical research experience who has had roles of increasing responsibility and scope at MGH/Harvard Medical School, SUNY Upstate Medical University, Schering-Plough, Sanofi-Aventis, Merck, BioClinica, Merck Sharp & Dohme Corp, GE Healthcare, and Novartis Consumer Health. All his industry roles have involved the application of imaging, biomarkers and clinical neuroscience to drug development. Dr. Grachev is a member of the Coalition Against Major Diseases (CAMD), QIBA DCE-MRI, FDG- and amyloid-PET steering committees of RSNA, ADNI and ADNI2, Society of Nuclear Medicine, International Society to Advance Alzheimer Research and Treatment and has written and co-authored over 100 clinical research scientific publications including chapters on imaging biomarkers/technologies in three books “Methods in Pain Research (CRC Press),” “Complex Regional Pain Syndrome (IASP Press)” and “Imaging in CNS Drug Development (Springer Science, NY),” and served as a Chair of Industry Scientific Advisory Board for Parkinson’s Progression Markers Initiative, Michael J. Fox Foundation. Research interest: Neurobiology of Neurodegenerative disorders (Parkinson’s disease, Alzheimer’s disease, Multiple Sclerosis), Insomnia (incl. PSG), OCD, Depression, Anxiety, Schizophrenia, ADHD, Migraine, Acute & Chronic Pain, Stroke and other indications. Expert in clinical biomarkers and the following Imaging modalities: PET, SPECT, and MRI (Gd-MRI, vMRI, fMRI, MRS, DCE-MRI).

Dr.Olga Mozenska, MD, PhD graduated from Medical University of Warsaw, Poland. She did parts of her medical degree abroad at University Studi degli di Milano in Milan, Italy and at Harvard Medical School (Massachusetts General Hospital and Brigham and Women’s Hospital). She did several international clerkships, ie. German Heart Centre in Munich, Germany, Toho Medical University in Tokio, Japan, Royal Brompton and Harefield, London, UK. She is a board-certified cardiologist and holds a certification in travel medicine. Her main clinical and research interests lie within valvular and structural heart disease as well as within cardiac multimodality imaging. She works in the Department of Internal Medicine, Hypertension and Angiology in the Independent Public Central Clinical Hospital, Medical University of Warsaw, in Warsaw, Poland. She published over 60 articles (original, review and case reports as well as chapters in cardiology books) and is the first author or co-author of several abstracts and posters presented at international Congresses (EuroEcho, ESC, EuroPCR, PCR London Valves, Heart Failure). She is a member of European Society of Cardiology, European Association of Cardiovascular Imaging Club 35 and Society of Cardiovascular Computed Tomography.

Dr. Fernando Estévez was Clinical Neurologist Specialist in Neurology from University of Chile.He has done Msc Magister on line in neuroscience and behavioral biology. Pablo de Olavide University, Seville – Spain, MA Master in Bioethics and Law Health Problems and Biotechnology from the University of Barcelona. .Phd from Doctor from the University of Barcelona in Law and Political Science -Bioethics mention from the University of Barcelona.

Dr. Jana I. Preis is currently working on Chief, Division of infectious Diseases and Clinical Epidemiology, Brooklyn VA Medical Center, usa. she has got her Ph.D. from Ross University School of Medicine, Iselin, USA.

Michael W. Lew is currently working an Clinical Professor in Department of Anesthesiology, City of Hope National Medical Center, USA. He got him Ph.D from University of Southern California, Keck School of Medicine, Los Angeles, California, USA.

Dr. Het Patel, is a Clinical scientist Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, MA, United States